Global Oral Solid Dosage Excipients Market estimated to be US$ 5.9 billion by 2030 with a CAGR of 7.9% during the forecast period - by PMI
March 02, 2021 10:05 ET
|
PMI
Covina CA, March 02, 2021 (GLOBE NEWSWIRE) -- Global Oral Solid Dosage Excipients Market accounted for US$ 2.8 billion in 2020 and is estimated to be US$ 5.9 billion by 2030 and is anticipated to...
Global Schizophrenia Drug Market is estimated to be US$ 9.8 Bn by 2030 with a CAGR of 2.7% during the forecast period - by PMI
February 24, 2021 10:05 ET
|
PMI
Covina CA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The global schizophrenia drug market accounted for US$ 7.5 Bn in 2020 and is estimated to be US$ 9.8 Bn by 2030 and is anticipated to register a CAGR of...
QUANTA Appoints Dr Selwayan Saini as Chief Operating Officer
February 12, 2021 03:00 ET
|
Quanta Dialysis Technologies
QUANTA Appoints Dr Selwayan Saini as Chief Operating Officer Alcester, Warwickshire, UK, 12 February 2021: QUANTA Dialysis Technologies Ltd (“QUANTA” or the “Company”), a British medical...
Global Digitalization of Beauty Industry Market have grown to become a more than US$160Bnindustry, with CAGR of 5.5% over the coming years 2020 – 2029. - by PMI
February 09, 2021 10:05 ET
|
PMI
Covina CA, Feb. 09, 2021 (GLOBE NEWSWIRE) -- The global digitalization of the beauty industry market is expected to grow at a significant growth rate during the forecast period 2020 – 2029. The...
Global Pain Management Devices Market – Growing Demand for Long-Term Pain Management among the Geriatric Population, Strong Product Pipeline for Pain Management Devices etc. driving market growth - by PMI
January 19, 2021 11:05 ET
|
PMI
Covina CA, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Growing demand for long-term pain management among the geriatric population, large patient population base, adverse effects of pain medications,...
MediPharm Labs Reports Second Quarter 2020 Results, Strong Progress With International Expansion
August 13, 2020 07:01 ET
|
MediPharm Labs Corp.
BARRIE, Ontario, Aug. 13, 2020 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven...
UIC Law’s IP Program Plans Several Programs and Initiatives for Fall 2020
July 14, 2020 16:33 ET
|
The John Marshall Law School
Chicago, Illinois, July 14, 2020 (GLOBE NEWSWIRE) -- On September 11, 2020, senior counsel from Microsoft, Google, Johnson & Johnson, Estée Lauder, the Motion Picture Association of America and...
Global COVID-19 Impact on Vaccines & Drugs Market growth is mainly attributed due to growing number of people infected with COVID-19 and rising funding for vaccine development - PMI
June 22, 2020 11:05 ET
|
PMI
Covina, CA, June 22, 2020 (GLOBE NEWSWIRE) -- The global COVID-19 vaccines market accounted for US$ 2.6 billion in 2020 and is estimated to be US$ 1.5 billion by 2025 and is anticipated to register...
Minerva Neurosciences Announces Positive Top Line Results in Phase 2b Clinical Trial With Seltorexant (MIN-202) in Treatment of Depressed Patients With an Inadequate Response to SSRIs and SNRIs
May 13, 2019 08:15 ET
|
Minerva Neurosciences, Inc
Potential first-in-class, oral specific orexin-2 inhibitor demonstrates statistically significant improvement in MADRS scores at 6 weeks compared to placebo Well tolerated, with adverse events similar...
Bragar Eagel & Squire, P.C. is Investigating Johnson & Johnson (JNJ) on Behalf of Stockholders and Encourages JNJ Investors to Contact the Firm
December 14, 2018 18:45 ET
|
Bragar Eagel & Squire
NEW YORK, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Johnson & Johnson (NYSE: JNJ). Our investigation concerns whether Johnson...